Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.17 $30,095 - $52,554
44,918 New
44,918 $32,000
Q4 2022

Feb 14, 2023

SELL
$4.78 - $15.01 $82,302 - $258,442
-17,218 Reduced 56.2%
13,418 $70,000
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $73,849 - $171,256
7,226 Added 30.87%
30,636 $353,000
Q2 2022

Aug 15, 2022

BUY
$4.35 - $15.85 $101,833 - $371,048
23,410 New
23,410 $265,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.